Functional characterization of 21 CYP3A4 variants on amiodarone metabolism in vitro.
- Published in:
- Xenobiotica, 2019, v. 49, n. 1, p. 120, doi. 10.1080/00498254.2017.1414971
- By:
- Publication type:
- Article
Works matching AU Tang, Peng-Fei
Results: 10
1
2
Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism.
- Published in:
- Drug Design, Development & Therapy, 2020, v. 14, p. 5129, doi. 10.2147/DDDT.S268796
- By:
- Publication type:
- Article
3
Nanoarchitectonics and catalytic performances of metal–organic frameworks supported metal nanoparticles.
- Published in:
- Applied Organometallic Chemistry, 2024, v. 38, n. 1, p. 1, doi. 10.1002/aoc.7308
- By:
- Publication type:
- Article
4
Research on In Situ Stress Measurements in Reinforced Concrete Beams Based on the Core-Drilling Method.
- Published in:
- Advances in Civil Engineering, 2020, p. 1, doi. 10.1155/2020/8832614
- By:
- Publication type:
- Article
5
The relationship between CYP2C9 gene polymorphisms and azilsartan metabolism in vitro.
- Published in:
- Expert Opinion on Drug Metabolism & Toxicology, 2025, v. 21, n. 1, p. 95, doi. 10.1080/17425255.2024.2409255
- By:
- Publication type:
- Article
6
Four New Limonoids from the Barks of Toona ciliata.
- Published in:
- Natural Products & Bioprospecting, 2021, v. 11, n. 1, p. 81, doi. 10.1007/s13659-020-00274-w
- By:
- Publication type:
- Article
7
Determination of lesinurad in rat plasma by a UHPLC-MS/MS assay.
- Published in:
- Chemistry Central Journal, 2017, v. 11, n. 1, p. 1, doi. 10.1186/s13065-017-0353-6
- By:
- Publication type:
- Article
8
Development of a Rapid LC‐MS/MS Method and Its Application for the Pharmacokinetic Analysis of Pacritinib in Rats.
- Published in:
- Journal of Mass Spectrometry, 2025, v. 60, n. 5, p. 1, doi. 10.1002/jms.5142
- By:
- Publication type:
- Article
9
Development and application of a UHPLC-MS/MS method for the simultaneous determination of firmonertinib and its main metabolite AST-5902 in rat plasma: a study on the in vivo drug interaction between firmonertinib and paxlovid.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1570206
- By:
- Publication type:
- Article
10
A novel UHPLC‒MS/MS method for quantitative analysis of zanubrutinib in rat plasma: application to an in vivo interaction study between zanubrutinib and triazole antifungal.
- Published in:
- BMC Chemistry, 2023, v. 17, n. 1, p. 1, doi. 10.1186/s13065-023-01017-x
- By:
- Publication type:
- Article